News H2 Global Group – Approval of the First SÚKL Clinical Trial for Molecular Hydrogen Inhalation H2 Global Group – Approval of the First SÚKL Clinical Trial for Molecular Hydrogen Inhalation 11. 12. 2025 Share Tweet Pin It